Literature DB >> 22711281

Oxidative stress, Nox isoforms and complications of diabetes--potential targets for novel therapies.

Mona Sedeek1, Augusto C Montezano, Richard L Hebert, Stephen P Gray, Elyse Di Marco, Jay C Jha, Mark E Cooper, Karin Jandeleit-Dahm, Ernesto L Schiffrin, Jennifer L Wilkinson-Berka, Rhian M Touyz.   

Abstract

Most diabetes-related complications and causes of death arise from cardiovascular disease and end-stage renal disease. Amongst the major complications of diabetes mellitus are retinopathy, neuropathy, nephropathy and accelerated atherosclerosis. Increased bioavailability of reactive oxygen species (ROS) (termed oxidative stress), derived in large part from the NADPH oxidase (Nox) family of free radical producing enzymes, has been demonstrated in experimental and clinical diabetes and has been implicated in the cardiovascular and renal complications of diabetes. The present review focuses on the role of Noxs and oxidative stress in some major complications of diabetes, including nephropathy, retinopathy and atherosclerosis. We also discuss Nox isoforms as potential targets for therapy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22711281     DOI: 10.1007/s12265-012-9387-2

Source DB:  PubMed          Journal:  J Cardiovasc Transl Res        ISSN: 1937-5387            Impact factor:   4.132


  107 in total

Review 1.  Oxidative stress and diabetic cardiovascular complications.

Authors:  Desmond Jay; Hirofumi Hitomi; Kathy K Griendling
Journal:  Free Radic Biol Med       Date:  2005-11-10       Impact factor: 7.376

2.  Activation of nicotinamide adenine dinucleotide phosphate (reduced form) oxidase by advanced glycation end products links oxidative stress to altered retinal vascular endothelial growth factor expression.

Authors:  Ling Li; Geneviève Renier
Journal:  Metabolism       Date:  2006-11       Impact factor: 8.694

3.  Reduction of diabetes-induced oxidative stress, fibrotic cytokine expression, and renal dysfunction in protein kinase Cbeta-null mice.

Authors:  Yuzuru Ohshiro; Ronald C Ma; Yutaka Yasuda; Junko Hiraoka-Yamamoto; Allen C Clermont; Keiji Isshiki; Kunimasa Yagi; Emi Arikawa; Timothy S Kern; George L King
Journal:  Diabetes       Date:  2006-11       Impact factor: 9.461

4.  Nox4-derived reactive oxygen species mediate cardiomyocyte injury in early type 1 diabetes.

Authors:  Rita M Maalouf; Assaad A Eid; Yves C Gorin; Karen Block; Gladys Patricia Escobar; Steven Bailey; Hanna E Abboud
Journal:  Am J Physiol Cell Physiol       Date:  2011-10-26       Impact factor: 4.249

5.  The p47phox- and NADPH oxidase organiser 1 (NOXO1)-dependent activation of NADPH oxidase 1 (NOX1) mediates endothelial nitric oxide synthase (eNOS) uncoupling and endothelial dysfunction in a streptozotocin-induced murine model of diabetes.

Authors:  J Y Youn; L Gao; H Cai
Journal:  Diabetologia       Date:  2012-05-02       Impact factor: 10.122

6.  NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart.

Authors:  Junya Kuroda; Tetsuro Ago; Shouji Matsushima; Peiyong Zhai; Michael D Schneider; Junichi Sadoshima
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-16       Impact factor: 11.205

7.  Comparative pharmacology of chemically distinct NADPH oxidase inhibitors.

Authors:  S Wind; K Beuerlein; T Eucker; H Müller; P Scheurer; M E Armitage; H Ho; H H H W Schmidt; K Wingler
Journal:  Br J Pharmacol       Date:  2010-10       Impact factor: 8.739

8.  Increased expression of NAD(P)H oxidase subunits, NOX4 and p22phox, in the kidney of streptozotocin-induced diabetic rats and its reversibity by interventive insulin treatment.

Authors:  T Etoh; T Inoguchi; M Kakimoto; N Sonoda; K Kobayashi; J Kuroda; H Sumimoto; H Nawata
Journal:  Diabetologia       Date:  2003-09-12       Impact factor: 10.122

9.  Renal redox-sensitive signaling, but not blood pressure, is attenuated by Nox1 knockout in angiotensin II-dependent chronic hypertension.

Authors:  Alvaro Yogi; Chantal Mercure; Joshuah Touyz; Glaucia E Callera; Augusto C I Montezano; Anna B Aranha; Rita C Tostes; Timothy Reudelhuber; Rhian M Touyz
Journal:  Hypertension       Date:  2008-01-14       Impact factor: 10.190

Review 10.  NADPH oxidases: functions and pathologies in the vasculature.

Authors:  Bernard Lassègue; Kathy K Griendling
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-11-12       Impact factor: 8.311

View more
  39 in total

Review 1.  MicroRNAs in diabetic nephropathy: functions, biomarkers, and therapeutic targets.

Authors:  Mitsuo Kato; Rama Natarajan
Journal:  Ann N Y Acad Sci       Date:  2015-04-15       Impact factor: 5.691

Review 2.  Epigenetics and epigenomics in diabetic kidney disease and metabolic memory.

Authors:  Mitsuo Kato; Rama Natarajan
Journal:  Nat Rev Nephrol       Date:  2019-06       Impact factor: 28.314

Review 3.  Scar management in burn injuries using drug delivery and molecular signaling: Current treatments and future directions.

Authors:  Saeid Amini-Nik; Yusef Yousuf; Marc G Jeschke
Journal:  Adv Drug Deliv Rev       Date:  2017-07-27       Impact factor: 15.470

Review 4.  Regulation of cellular communication by signaling microdomains in the blood vessel wall.

Authors:  Marie Billaud; Alexander W Lohman; Scott R Johnstone; Lauren A Biwer; Stephanie Mutchler; Brant E Isakson
Journal:  Pharmacol Rev       Date:  2014-03-26       Impact factor: 25.468

Review 5.  Spermine oxidase: A promising therapeutic target for neurodegeneration in diabetic retinopathy.

Authors:  S Priya Narayanan; Esraa Shosha; Chithra D Palani
Journal:  Pharmacol Res       Date:  2019-06-15       Impact factor: 7.658

Review 6.  Evolution of NADPH Oxidase Inhibitors: Selectivity and Mechanisms for Target Engagement.

Authors:  Sebastian Altenhöfer; Kim A Radermacher; Pamela W M Kleikers; Kirstin Wingler; Harald H H W Schmidt
Journal:  Antioxid Redox Signal       Date:  2014-02-26       Impact factor: 8.401

7.  Potential Role of Endoplasmic Reticulum Stress in Pathogenesis of Diabetic Retinopathy.

Authors:  Gustavo Sánchez-Chávez; Ernesto Hernández-Ramírez; Ixchel Osorio-Paz; Claudia Hernández-Espinosa; Rocío Salceda
Journal:  Neurochem Res       Date:  2015-12-31       Impact factor: 3.996

Review 8.  Nox4 and diabetic nephropathy: with a friend like this, who needs enemies?

Authors:  Yves Gorin; Karen Block
Journal:  Free Radic Biol Med       Date:  2013-03-23       Impact factor: 7.376

9.  NADPH oxidase-generated reactive oxygen species are required for stromal cell-derived factor-1α-stimulated angiogenesis.

Authors:  Xinchun Pi; Liang Xie; Andrea L Portbury; Sarayu Kumar; Pamela Lockyer; Xi Li; Cam Patterson
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-07-02       Impact factor: 8.311

Review 10.  Reactive oxygen species, vascular Noxs, and hypertension: focus on translational and clinical research.

Authors:  Augusto C Montezano; Rhian M Touyz
Journal:  Antioxid Redox Signal       Date:  2013-06-06       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.